NEWS
![](https://perpetuum.bio/wp-content/uploads/2020/08/p-web-blog06-300x188.png)
vaccines
Polydendritic Nano-Adjuvant
Perpetuum starts pre-clinical stage investigation of it’s proprietary Polydendritic Nano-Adjuvants for novel vaccination strategies.
15/07/2020
![](https://perpetuum.bio/wp-content/uploads/2020/08/p-web-blog04-300x188.png)
nutraceuticals
Ombium Launch
Perpetuum launches it’s new brand Ombium, a nutritional supplement line targeting metabolic syndrome risk factors.
03/06/2020
![](https://perpetuum.bio/wp-content/uploads/2020/08/p-web-blog01-300x188.png)
cosmetic
Dermium Launch
Perpetuum set to launch the world’s first acne treatment based on it’s recombinant bacteriophage endolysin technology. Dermium is a development, technology & product from our sistercompany Asterion Therapeutics. Read more on dedicated website dermium.bio
09/02/2020
![](https://perpetuum.bio/wp-content/uploads/2020/08/p-web-blog05-300x188.png)
cosmetic
China Division
Perpetuum opens new division in China for the sales of it’s cosmetic consumer brands throughout APAC.
03/03/2019